Top compounds associated with response to HIKESHI


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:BRD-A02303741 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.12 0.0004
mRNA BRD-K80183349 CTRPv2 pan-cancer AAC -0.11 0.0005
mRNA selumetinib:piperlongumine (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.12 0.0005
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.12 0.0007
mRNA Compound 23 citrate CTRPv2 pan-cancer AAC -0.11 0.0009
mRNA selumetinib:decitabine (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.11 0.001
mRNA GSK525762A CTRPv2 pan-cancer AAC -0.098 0.001
mRNA BRD-K85133207 CTRPv2 pan-cancer AAC -0.12 0.001
mRNA selumetinib:JQ-1 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.11 0.001
mRNA Crizotinib CTRPv2 pan-cancer AAC -0.11 0.001
Download CSV